ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997

Supreme Court Declines Appeal on Access to Experimental Therapies.

January 18, 2008

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Final Issue of 1981

December 11, 1981

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000